EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry

Jane Koo iD, Melissa Gerstle iD, Leah Cheng, Richard Cooper, Katherine Coyne, Claire Dusa, Naomi E Joffe iD, Diana Schwarz iD, Sarah Steltz, Akiko Shimamura, Kasiani C Myers iD, Thea Quinton iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Jane Koo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Shwachman-Diamond Syndrome, Registries, Bone Marrow Diseases, Lipomatosis. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy characterized by bone marrow failure and multisystem involvement, with emerging evidence of associated neurocognitive impairment.

Methods

We conducted a retrospective study of 240 individuals with biallelic Shwachman–Bodian–Diamond syndrome (SBDS) mutations enrolled in the North American SDS Registry to characterize neuropsychological, psychiatric, educational, functional, and neuroimaging outcomes. Medical records were reviewed, and neuropsychological scores were converted to z ‐scores and categorized as weakness (1.0–1.4 SD below the mean) or impairment (≥1.5 SD below the mean).

Results

Fourteen individuals completed formal neuropsychological evaluations (mean age 10.66 years). Median full‐scale IQ z ‐score was −0.47 (SD 1.28), with 41.7% demonstrating intellectual weakness or impairment. Adaptive functioning showed the highest rate of impairment (100%). Executive functioning, visual‐motor integration, spelling, and mathematics were commonly affected, whereas immediate verbal learning was preserved. Longitudinal data from five patients demonstrated stable overall intellectual and generally stable adaptive functioning over time, with variability in higher order cognitive and psychosocial domains. Educational support needs were substantial: 73.9% required specialized educational programs and 51.9% had an individualized education program. Neurodevelopmental disorders were reported in 49% of those with available data, most commonly attention‐deficit/hyperactivity disorder, and 23.5% had mental health diagnoses, most frequently anxiety. Neuroimaging was abnormal in a subset, most often reflecting structural brain differences.

Conclusions

These findings indicate that individuals with SDS are at elevated risk for neurocognitive weaknesses and significant educational needs. Although global intellectual functioning appears relatively stable over time, domain‐specific vulnerabilities and adaptive impairment warrant routine neuropsychological monitoring and early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shwachman-Diamond SyndromeRegistriesBone Marrow DiseasesLipomatosisExocrine Pancreatic InsufficiencyHumansFemaleChildMaleRetrospective StudiesAdolescentNeuropsychological TestsChild, PreschoolFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

Shwachman–Diamond syndromedevelopmentneuropsychological evaluation

Autor:innen und Institutionen

  • Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Clinical Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Jane Koo, Melissa Gerstle, Naomi E Joffe, Diana Schwarz, Kasiani C Myers, Thea Quinton

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Koo, J., Gerstle, M., Cheng, L., Cooper, R., Coyne, K., Dusa, C., Joffe, N. E., Schwarz, D., Steltz, S., Shimamura, A., Myers, K. C., & Quinton, T. (2026). Neuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70650

Vancouver

Koo J, Gerstle M, Cheng L, Cooper R, Coyne K, Dusa C, et al. Neuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70650

BibTeX
@article{Koo2026,
  author = {Koo, Jane and Gerstle, Melissa and Cheng, Leah and Cooper, Richard and Coyne, Katherine and Dusa, Claire and Joffe, Naomi E and Schwarz, Diana and Steltz, Sarah and Shimamura, Akiko and Myers, Kasiani C and Quinton, Thea},
  title = {Neuropsychological and Educational Outcomes in Shwachman–Diamond Syndrome—A Report From the North American Shwachman–Diamond Syndrome Registry},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70650}
}
Kostenlos starten →